zoledronic acid has been researched along with Scleritis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Debiais, F; Inglard, C; Larid, G; Mahe, J; Roy-Peaud, F | 1 |
| Niederer, R; Samalia, P; Sims, J | 1 |
| Lecler, A; Provost, C; Sené, T | 1 |
| Watts, AR; Wolpert, LE | 1 |
| Al-Abuwsi, F; Bolland, M; Horne, A; McGhee, CN; Nisa, Z; Patel, DV; Reid, IR; Singh, M | 1 |
| Badros, A; Benderson, D; Karakunnel, J; Kathuria, S | 1 |
| Beith, JM; Moore, MM | 1 |
1 review(s) available for zoledronic acid and Scleritis
| Article | Year |
|---|---|
Scleritis complicating zoledronic acid infusion.
Topics: Aged; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Male; Multiple Myeloma; Pamidronate; Radiography; Scleritis; Zoledronic Acid | 2006 |
1 trial(s) available for zoledronic acid and Scleritis
| Article | Year |
|---|---|
Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.
Topics: Acute Disease; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Incidence; Infusions, Intravenous; Middle Aged; Postmenopause; Prospective Studies; Scleritis; Treatment Outcome; Uveitis, Anterior; Zoledronic Acid | 2015 |
5 other study(ies) available for zoledronic acid and Scleritis
| Article | Year |
|---|---|
Zoledronic acid-induced posterior scleritis associated with inflammatory orbitopathy.
Topics: Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Scleritis; Zoledronic Acid | 2022 |
Drug-induced ocular inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alendronate; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Brimonidine Tartrate; Diphosphonates; ErbB Receptors; Erlotinib Hydrochloride; Etanercept; Female; Humans; Imidazoles; Immune Checkpoint Inhibitors; Male; Middle Aged; Nivolumab; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Scleritis; Uveitis, Anterior; Vemurafenib; Zoledronic Acid | 2020 |
Bisphosphonate-induced Posterior Scleritis.
Topics: Bone Density Conservation Agents; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Osteoporosis; Posterior Eye Segment; Scleritis; Zoledronic Acid | 2021 |
Zoledronate-induced anterior uveitis, scleritis and optic neuritis: a case report.
Topics: Bone Density Conservation Agents; Female; Humans; Middle Aged; Optic Neuritis; Scleritis; Uveitis, Anterior; Zoledronic Acid | 2021 |
Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
Topics: Acute Disease; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Scleritis; Uveitis, Anterior; Zoledronic Acid | 2008 |